Correlation between apparent diffusion coefficient and pathological characteristics of patients with invasive breast cancer
暂无分享,去创建一个
Jiandong Wang | Lin Tian | Baoshi Bao | Yuhui Chen | Y. Qiu | Hongye Chen | Xiu-jin Zhang | Wuyao Yang
[1] Canjian Chen,et al. The expression of KI-67 and LEF-1 in patients after breast cancer resection and its effects on patients' prognosis. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[2] M. Herranz,et al. Apparent diffusion coefficient: Potential biomarker for complete response after neo‐adjuvant chemotherapy in breast cancer , 2020, The breast journal.
[3] W. Han,et al. Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer , 2019, Journal of oncology.
[4] Xiao-Ting Li,et al. Texture Analysis of Dynamic Contrast-Enhanced MRI in Evaluating Pathologic Complete Response (pCR) of Mass-Like Breast Cancer after Neoadjuvant Therapy , 2019, Journal of oncology.
[5] F. Prato,et al. DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR , 2019, Clinical and translational radiation oncology.
[6] M. de Camargo Cancela,et al. Association of cervical and breast cancer mortality with socioeconomic indicators and availability of health services. , 2019, Cancer epidemiology.
[7] C. Castañeda,et al. Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach , 2019, Front. Oncol..
[8] N. Gudzenko,et al. EPIDEMIOLOGY OF BREAST CANCER IN UKRAINE WITH CONSIDERATION OF THE FACTORS OF THE CHORNOBYL ACCIDENT. , 2019, Problemy radiatsiinoi medytsyny ta radiobiolohii.
[9] M. F. Ariffin,et al. Modelling excess mortality among breast cancer patients in the North East Region of Peninsular Malaysia, 2007–2011: a population-based study , 2019, BMC Public Health.
[10] Lihua Li,et al. Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics , 2019, IEEE Journal of Biomedical and Health Informatics.
[11] C. Hsiung,et al. Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women. , 2019, The oncologist.
[12] G. Spinelli,et al. Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy , 2019, Cancer Chemotherapy and Pharmacology.
[13] W. Weichert,et al. Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results , 2019, Breast.
[14] C. Gatsonis,et al. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up. , 2019, Journal of breast imaging.
[15] S. Partridge,et al. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis , 2019, BMC Cancer.
[16] B. Choi. Associations Between Apparent Diffusion Coefficient Values and the Prognostic Factors of Breast Cancer. , 2019, Journal of computer assisted tomography.
[17] Yinan Ji,et al. Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer. , 2019, Academic radiology.
[18] Weihua Guo,et al. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma in situ , 2019, Journal of cancer research and therapeutics.
[19] Şehnaz Tezcan,et al. Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors. , 2019, European journal of breast health.
[20] Kui Li,et al. Diagnostic value of diffusion-weighted imaging-derived apparent diffusion coefficient and its association with histological prognostic factors in breast cancer , 2019, Oncology letters.
[21] M. Mańczuk,et al. Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+) , 2019, Archives of medical science : AMS.
[22] P. Omoregie,et al. Epidemiology and Challenges of Managing Breast Cancer in Keffi, North-Central Nigeria: A Preliminary Report , 2019, Nigerian medical journal : journal of the Nigeria Medical Association.
[23] A. Kasaeian,et al. Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study , 2019, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[24] N. Sood. Ki-67, an elusive marker in the prognosis of breast cancer , 2019, The Indian journal of medical research.
[25] M. Nakano,et al. Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors. , 2018, Oncology letters.